Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer

BACKGROUND & AIMS: Although hepatocellular cancers (HCC) frequently arise in the setting of fibrosis and a hepatic regenerative response requiring new cell growth, therapeutic strategies for these cancers have not targeted protein synthesis. Silvestrol, a rocaglate isolated from Aglaia foveolata...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kogure, Takayuki, Kinghorn, A. Douglas, Yan, Irene, Bolon, Brad, Lucas, David M., Grever, Michael R., Patel, Tushar
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3784426/
https://ncbi.nlm.nih.gov/pubmed/24086701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0076136
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars